Showing 1-10 of 30 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Reducing Health Disparities and Improving Outcomes in Type 1 Diabetes Through a Novel Community-Focused Digital Care Model | Blue Circle Health | Leonard D'Avolio | Mission | 01-January-2026 to 31-December-2028 | $1.500.000,00 |
| GNTI-122 for the treatment of recently diagnosed type 1 diabetes | GentiBio | Mark Bach | Cures | 01-December-2025 to 30-November-2027 | $4.000.000,00 |
| Engineering fully vascularized SC-islets through endothelial integration and endocrine-vascular crosstalk | Boston Children's Hospital | Juan Melero-Martin | Cures | 01-November-2025 to 31-October-2027 | $599.994,46 |
| ALIGN-T1D Start-Up Secretariat | Clinton Health Access Initiative (CHAI) | Colin Brown | Mission | 01-October-2025 to 31-March-2027 | $2.282.397,10 |
| A Cure for Type 1 Diabetes | University of Massachusetts Medical School | David Harlan | Cures | 01-October-2025 to 30-September-2029 | $16.000.000,00 |
| Understanding common tissue tolerance mechanisms in autoimmunity | Massachusetts General Hospital | Gary Reynolds | Cures | 01-September-2025 to 31-August-2026 | $150.000,00 |
| A wireless oxygen generating immune protection device to support long term cell transplantation for the treatment of Type I Diabetes | Boston Children's Hospital | Robert Langer | Cures | 01-August-2025 to 31-July-2028 | $2.481.286,98 |
| Innovation Partnership | LabCentral | Luke Wallrich | Cures | 07-July-2025 to 31-May-2026 | $200.000,00 |
| Targeting RNLS for Type 1 Diabetes Therapy | Joslin Diabetes Center Inc. | Peng Yi | Cures | 01-June-2025 to 31-May-2028 | $1.349.997,00 |
| T1D Global Access Grand Strategy | Clinton Health Access Initiative (CHAI) | Colin Brown | Mission | 01-August-2024 to 30-September-2025 | $1.176.383,80 |